Sphingosine 1-Phosphate Induces Cyclooxygenase-2/Prostaglandin E2 Expression via PKCα-dependent Mitogen-Activated Protein Kinases and NF-κB Cascade in Human Cardiac Fibroblasts

In the regions of tissue injuries and inflammatory diseases, sphingosine 1-phosphate (S1P), a proinflammatory mediator, is increased. S1P may induce the upregulation of cyclooxygenase-2 (COX-2)/prostaglandin E-2 (PGE(2)) system in various types of cells to exacerbate heart inflammation. However, the detailed molecular mechanisms by which S1P induces COX-2 expression in human cardiac fibroblasts (HCFs) remain unknown. HCFs were incubated with S1P and analyzed by Western blotting, real time-Polymerase chain reaction (RT-PCR), and immunofluorescent staining. Our results indicated that S1P activated S1PR(1/3)-dependent transcriptional activity to induce COX-2 expression and PGE(2) production. S1P recruited and activated PTX-sensitive G(i) or -insensitive G(q) protein-coupled S1PR and then stimulated PKC alpha-dependent phosphorylation of p42/p44 MAPK, p38 MAPK, and JNK1/2, leading to activating transcription factor NF-kappa B. Moreover, S1P-activated NF-kappa B was translocated into the nucleus and bound to its corresponding binding sites on COX-2 promoters determined by chromatin immunoprecipitation (ChIP) and promoter-reporter assays, thereby turning on COX-2 gene transcription associated with PGE(2) production in HCFs. These results concluded that in HCFs, activation of NF-kappa B by PKC alpha-mediated MAPK cascades was essential for S1P-induced up-regulation of the COX-2/PGE(2) system. Understanding the mechanisms of COX-2 expression and PGE(2) production regulated by the S1P/S1PRs system on cardiac fibroblasts may provide rationally therapeutic interventions for heart injury or inflammatory diseases.